By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Faron Pharmaceuticals Ltd. 

Tykistökatu 6 B, BioCity

Turku    FIN-20520  Finland
Phone: 358-2-469-5151 Fax: 358-2-469-5152



Company News
Faron Pharmaceuticals Ltd. Release: Positive Top-Line Results From The Japanese Phase II Study Of Traumakine For The Treatment Of ARDS 1/7/2016 11:09:31 AM
Faron Pharmaceuticals Ltd. Release: First Patient Recruited In Pan-European Phase III INTEREST Study For Treatment Of Acute Respiratory Distress Syndrome 12/29/2015 8:40:34 AM
Faron Pharmaceuticals Ltd. Awarded €1.5 Million Tekes Funding To Progress Novel Cancer Immunotherapy Clevegen 12/21/2015 12:31:46 PM
Faron Pharmaceuticals Ltd. Release: Admission To AIM And First Day Of Dealings £10 Million Fundraise To Progress Phase III Clinical Trial 11/17/2015 10:51:34 AM
Faron Pharmaceuticals Ltd. Enters Agreement With Selexis SA To Progress Development Of Novel Cancer Immunotherapy Clevegen 11/3/2015 9:26:41 AM
Faron Pharmaceuticals Ltd. Announces Collaboration With Turku PET Centre On Development Of Novel Cancer Immunotherapy 6/30/2015 9:31:37 AM
China Medical Systems In-Licenses Respiratory Distress Drug From Faron Pharmaceuticals Ltd. 5/20/2015 3:09:13 PM
Faron Pharmaceuticals Ltd. Release: Headline Data Fromfrom Thethe Clinical Study Withwith FP-1201 Inin Acute Lung Injuries Demonstrates Aa Significant Decrease Inin Mortality 5/9/2011 11:17:05 AM
Rentschler Biotechnologie GmbH & Co. to Manufacture Faron Pharmaceuticals Ltd. Product Traumakine(R) 1/18/2011 12:23:26 PM